Morgan Stanley Maintains Equal-Weight on Ovintiv, Lowers Price Target to $65
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Equal-Weight and lowers the price target from $68 to $65.
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Equal-Weight and lowers the price target from $68 to $65.